Symptomatic hip and knee osteoarthritis (OA) are among the most common causes of global disability 33. While already highly prevalent, the incidence and burden is anticipated to increase along with a concurrent increase in life expectancy of the general population and the obesity epidemic27,38. As such, optimal treatment strategies are required to minimize the impact of disease burden. Recently, clinical practice guidelines (CPG) for the treatment of knee OA have been established by the American Academy of Orthopedic Surgeons (AAOS), suggesting a comprehensive multimodal approach including physical therapy and injections, among other suggestions15. In subsequent months, the Arthroscopy Association of Canada (AAC) and Canadian Orthopaedic Association (COA) provided guidelines for the use of injections for the treatment of symptomatic knee OA based on the best-available literature35. However, similar recommendations for injections for the treatment of hip OA are lacking.
Scientist, CHEO Research Institute